scholarly journals In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit

2021 ◽  
Vol 10 (1) ◽  
pp. 274-278
Author(s):  
Yusuke Tomita ◽  
Bryan Oronsky ◽  
Nacer Abrouk ◽  
Pedro Cabrales ◽  
Tony R. Reid ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Cell Lung Cancer ◽  
Clinical Benefit ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab

Lung Cancer ◽  
2018 ◽  
Vol 120 ◽  
pp. 108-112 ◽  
Author(s):  
Nicolas Guibert ◽  
Myriam Delaunay ◽  
Amélie Lusque ◽  
Nadia Boubekeur ◽  
Isabelle Rouquette ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document